Trade with Eva: Analytics in action >>
Showing posts with label marijuana stocks. Show all posts
Showing posts with label marijuana stocks. Show all posts

Thursday, May 14, 2020

Aurora Cannabis (ACB) reported earnings on Thur 14 May 20 (a/h)

  • 5/14:  #1, 29, 75; vol 12.2M
** charts after earnings **








Aurora Cannabis Earnings Miss in Q3, on Track for Positive Earnings by 2021
  • Posts smaller sequential loss as pot use rises amid lockdown
  • The Canadian pot producer sold 12,729 kilograms of cannabis in the third quarter, 39% more than a year earlier. The sales spike comes as cannabis is an essential service in several provinces and states across Canada and the Unites States.
Aurora Cannabis (NYSE:ACB) said it was on track to deliver positive earnings by next year after reporting mixed third-quarter results as earnings fell short, but revenue topped expectations as the marijuana producer ramped up production.

"I am also pleased that our third quarter 2020 financial results were in-line with our expectations and that we remain firmly on track with the cost-savings and capex goals we detailed during our business transformation plan in February 2020," said Michael Singer, executive chairman and interim chief executive of Aurora.

SG&A costs in the third quarter of 2020 were $75.1 million, down $24.7 million from the prior quarter.

Aurora Cannabis reported third-quarter losses of C$1.37 a share, missing estimates for a loss of C$0.77. Revenue of C$75.5 million beat estimates of C$46.99 million.

The beat on the top line was led by strong performance in its consumer cannabis business, with revenue up 24% to $41.5 million year on year.

Production volume rose 18% to 36,207 kilograms in the quarter.

** next 3 days **



Saturday, July 13, 2019

Thursday, February 28, 2019

-=Arcadia Biosciences (RKDA) : new cannabis-focused business unit announced



Shares of Arcadia Biosciences (RKDA) rocketed 59% in very active trade, after the agricultural food ingredient company announced a new business unit focused on the cannabis.

  • The company said it will apply its expertise in breeding to improve the quality and nutritional content of wheat and soybeans, for the standardization of cannabis plant content, quality, climate resiliency and yield. 
  • The company said it will conduct its business only in federal and state markets in which its cannabis activities are legal. "Within the rapidly growing legal cannabis industry, we see enormous opportunity in--and demand for--improved plant quality, productivity, consistency and resilience," said Chief Executive Raj Ketkar. 


The stock has rallied 28.6% over the past three months through Wednesday, while the ETFMG Alternative Harvest ETF (MJ) has climbed 24.6% and the S&P 500 (SPX) has gained 1.8%.

Monday, December 10, 2018

=Aurora Cannabis (ACB) to acquire Farmacias Magistrales

Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange as ACB. As of late September 2018, Aurora Cannabis had eight licensed production facilities, five sales licenses, and operations in 18 countries.
Revenue: 18 million CAD (2017)
Headquarters: Vancouver, Canada
auroramj.com



As previously announced, Farmacias recently became Mexico's first and only federally licensed importer to date of raw materials containing THC, gaining the necessary licenses, facilities, and permissions to import raw THC material, and manufacture, store, and distribute medical cannabis products containing over 1% THC.
  • Consideration to be paid for the acquisition of Farmacias will be in shares of Aurora and based on a valuation of the proforma distribution revenue projections of Farmacias. The consideration payable by Aurora also includes a contingent portion of up to 25% payable only upon the achievement of certain milestones over the next 12 months related to operational metrics, such as maintaining market share.

Tuesday, November 13, 2018

Tilray (TLRY) reported earnings on Tue 13 Nov 2018 (a/h)

** charts before earnings ** 


  • 3 days before






** charts after earnings **

 




 Tilray beats by $0.04, revenue at low end of upside pre-announcement 
  • Reports Q3 (Sep) adj. loss of $0.08 per share, $0.04 better than the S&P Capital IQ Consensus of ($0.12); revenues rose 85.2% year/year to $10 mln vs the $10.25 mln S&P Capital IQ Consensus, driven by increased patient demand, bulk sales to other Licensed Producers, and accelerated wholesale distribution in export markets.
  • Preannounced rev $10.0-10.5 million vs. $9.9 mln ests last month.
  • Total kilogram equivalents sold increased over two-fold to 1,613 kilograms from 684 kilograms in the prior year. Average net selling price per gram was $6.21 (C$7.98) compared to $7.53 (C$9.34) for the three months ended September 30, 2017.

Monday, September 24, 2018

-=Intrexon (XON) : advances in production of medical cannabis



Intrexon announces advances in the development of its microbial platform to produce cannabinoids for medical uses
Through Intrexon's proprietary technologies, the Company has engineered a yeast strain to produce low-cost, robust and consistent cannabinoid outputs via fermentation. This process utilizing microbes has potential to provide greater supply-chain security, and avoids the resource-intensive isolation that often leads to quality and quantity variability in end products.
  • Further, this versatile strain was designed to enable the production of cannabinoids that only are produced today in miniscule amounts in cannabis plants as well as novel cannabinoids. The Company has scaled the process and achieved titers approaching commercially relevant targets with anticipated production of pure cannabinoids at COGS less than $1,000/kg.